Biomarkers for knee osteoarthritis: New technologies, new paradigms

Lucy Spain, Bashar Rajoub, Daniela K. Schlüter, John Waterton, Mike Bowes, Lik Kwan Shark, Peter Diggle, John Goodacre

Research output: Contribution to journalArticlepeer-review


There is a paucity of biomarkers in knee osteoarthritis (OA) to inform clinical decision making, evaluate treatments, enable early detection and identify people who are most likely to progress to severe OA. The absence of biomarkers places considerable limitations on the design of research studies, and is a barrier toward applying the principles of stratified medicine to knee OA. Here we describe key principles and processes of biomarker development and focus on two promising areas that draw upon technologies that have only relatively recently been developed for quantitative applications in clinical research, namely 3D MRI and acoustic emission. While still at an early stage, results to date show promising potential to open up interesting new paradigms in this field.

Original languageEnglish (US)
Pages (from-to)287-297
Number of pages11
JournalInternational Journal of Clinical Rheumatology
Issue number4
StatePublished - Aug 1 2015
Externally publishedYes


  • 3D MRI
  • acoustic emission
  • biomarker
  • knee osteoarthritis

ASJC Scopus subject areas

  • Rheumatology


Dive into the research topics of 'Biomarkers for knee osteoarthritis: New technologies, new paradigms'. Together they form a unique fingerprint.

Cite this